Results of prophylactic irradiation in patients with resected keloids--a retrospective analysis

• Published in: Acta oncologica Vol. 39; no. 2; p. 217
• Main Authors: Wagner, W, Alfrink, M, Micke, O, Schäfer, U, Schüller, P, Willich, N
• Format: Journal Article
• Language: English
• Published: England 2000
• Subjects: Adult; Brachytherapy; Combined Modality Therapy; Female; Humans; Keloid - pathology; Keloid - radiotherapy; Keloid - surgery; Male; Prognosis; Radiotherapy, Adjuvant; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome
• ISSN: 0284-186X
• DOI: 10.1080/028418600430806

The data of 139 patients with 166 keloids treated postoperatively between 1962 and 1996 were evaluated for prognostic factors and outcomes. Treatment commenced within 48 h after surgery. Radiotherapy was carried out as brachytherapy, using an integrated radionuclide 90 Sr-90Y surface applicator. The median dose delivered to the subcutis amounted to 14 Gy (range 7.5-28.5 Gy). The overall recurrence-free response rate was calculated to be 80% for all keloids. Response rates differed significantly (p < 0.001) between the different anatomical regions. The recurrence rate was lowest (2%) with keloids of the face and neck and highest with keloids of the thorax (49%). Outcome also differed significantly, depending on the etiology. Keloids following burns had a poorer success rate than those developing after surgery or mechanical trauma (p < 0.001). We were unable to demonstrate any significance in outcome related to gender, age or size. No direct correlation was found between total doses and response rates. In our patients there were no signs of secondary malignancies in the irradiation area within a median follow-up period of 12 years. Two new prognostic factors have been identified: keloid etiology and localization of the disorder.